Authors
Loading...
Pilot study characterizes treatment resistance mechanisms in high-grade serous ovarian cancer, suggesting new therapy targets.
Imbach et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: